$VIR
Vir Biotechnology, Inc.

2021 Form 10-K Financial Statement

#000095017022002295 Filed on February 28, 2022

View on sec.gov

Income Statement

Concept 2021 2020 Q4 2020
Revenue $1.095B $1.734M $76.37M
YoY Change 1334.39% 76.94% 843.86%
Cost Of Revenue $65.87M $0.00
YoY Change
Gross Profit $1.030B $76.37M
YoY Change 1248.14% 843.86%
Gross Profit Margin 93.99% 100.0%
Selling, General & Admin $160.8M $23.04M $70.94M
YoY Change 126.67% 95.09% 88.67%
% of Gross Profit 15.62% 92.89%
Research & Development $448.0M $87.10M $302.4M
YoY Change 48.14% 64.56% 103.68%
% of Gross Profit 43.51% 395.99%
Depreciation & Amortization $5.300M $1.330M $4.400M
YoY Change 20.45% 15.65% 33.33%
% of Gross Profit 0.51% 5.76%
Operating Expenses $608.8M $110.1M $373.3M
YoY Change 63.06% 70.13% 100.65%
Operating Profit $420.8M -$297.0M
YoY Change -241.68% 66.86%
Interest Expense $138.5M $290.0K $2.840M
YoY Change 4776.34% -85.13% -66.63%
% of Operating Profit 32.91%
Other Income/Expense, Net $129.1M $2.440M $1.631M
YoY Change 7812.39% -234.81% -147.28%
Pretax Income $549.8M -$105.7M -$298.6M
YoY Change -284.12% 66.11% 71.1%
Income Tax $21.22M -$30.00K $54.00K
% Of Pretax Income 3.86%
Net Earnings $528.6M -$105.6M -$298.7M
YoY Change -276.98% 65.67% 70.98%
Net Earnings / Revenue 48.25% -6092.79% -391.09%
Basic Earnings Per Share $4.07 -$0.83 -$2.51
Diluted Earnings Per Share $3.96 -$0.83 -$2.51
COMMON SHARES
Basic Shares Outstanding 129.9M 119.2M
Diluted Shares Outstanding 133.4M 119.2M

Balance Sheet

Concept 2021 2020 Q4 2020
SHORT-TERM ASSETS
Cash & Short-Term Investments $708.1M $736.9M $736.9M
YoY Change -3.9% 92.2% 92.2%
Cash & Equivalents $347.8M $436.6M $436.6M
Short-Term Investments $360.3M $300.3M $300.3M
Other Short-Term Assets $81.60M $35.50M $35.50M
YoY Change 129.85% 81.12% 81.12%
Inventory
Prepaid Expenses
Receivables $773.1M $0.00
Other Receivables $0.00
Total Short-Term Assets $1.563B $772.4M $772.4M
YoY Change 102.33% 91.66% 91.66%
LONG-TERM ASSETS
Property, Plant & Equipment $130.1M $17.95M $79.90M
YoY Change 62.77% 10.04% 390.18%
Goodwill $16.94M
YoY Change 0.0%
Intangibles $33.82M
YoY Change -5.25%
Long-Term Investments $201.4M
YoY Change
Other Assets $9.781M $15.70M $15.70M
YoY Change -37.7% -0.63% -0.63%
Total Long-Term Assets $391.4M $146.4M $146.4M
YoY Change 167.38% 34.21% 34.19%
TOTAL ASSETS
Total Short-Term Assets $1.563B $772.4M $772.4M
Total Long-Term Assets $391.4M $146.4M $146.4M
Total Assets $1.954B $918.8M $918.8M
YoY Change 112.7% 79.42% 79.42%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $6.521M $5.077M $5.100M
YoY Change 27.86% -13.67% -13.56%
Accrued Expenses $141.5M $76.70M $76.70M
YoY Change 84.5% 189.49% 191.63%
Deferred Revenue
YoY Change
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $300.0K $300.0K
YoY Change 50.0% 50.0%
Total Short-Term Liabilities $341.2M $99.06M $99.10M
YoY Change 244.34% 67.32% 67.4%
LONG-TERM LIABILITIES
Long-Term Debt $0.00 $700.0K $700.0K
YoY Change -100.0% -22.22% -22.22%
Other Long-Term Liabilities $162.7M $3.847M $98.90M
YoY Change 64.55% 7.82% 300.4%
Total Long-Term Liabilities $162.7M $3.847M $99.60M
YoY Change 63.39% 7.82% 289.06%
TOTAL LIABILITIES
Total Short-Term Liabilities $341.2M $99.06M $99.10M
Total Long-Term Liabilities $162.7M $3.847M $99.60M
Total Liabilities $522.4M $201.9M $201.9M
YoY Change 158.75% 129.11% 129.17%
SHAREHOLDERS EQUITY
Retained Earnings -$667.2M
YoY Change 81.04%
Common Stock $13.00K
YoY Change 18.18%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $1.432B $716.9M $716.9M
YoY Change
Total Liabilities & Shareholders Equity $1.954B $918.8M $918.8M
YoY Change 112.7% 79.42% 79.42%

Cashflow Statement

Concept 2021 2020 Q4 2020
OPERATING ACTIVITIES
Net Income $528.6M -$105.6M -$298.7M
YoY Change -276.98% 65.67% 70.98%
Depreciation, Depletion And Amortization $5.300M $1.330M $4.400M
YoY Change 20.45% 15.65% 33.33%
Cash From Operating Activities -$47.59M -$82.05M -$190.9M
YoY Change -75.08% 111.03% 47.29%
INVESTING ACTIVITIES
Capital Expenditures $21.82M -$2.430M $6.549M
YoY Change 233.13% 56.77% -26.74%
Acquisitions
YoY Change
Other Investing Activities -$119.0M $63.15M -$3.310M
YoY Change 3495.08% -187.44% -98.66%
Cash From Investing Activities -$140.8M $60.72M -$9.862M
YoY Change 1327.84% -182.31% -96.15%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net $0.00 $323.2M
YoY Change -100.0% 155.69%
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 100.3M -260.0K 529.5M
YoY Change -81.05% -100.2% 17.86%
NET CHANGE
Cash From Operating Activities -47.59M -82.05M -190.9M
Cash From Investing Activities -140.8M 60.72M -9.862M
Cash From Financing Activities 100.3M -260.0K 529.5M
Net Change In Cash -88.07M -21.59M 328.7M
YoY Change -126.8% -223.72% 417.97%
FREE CASH FLOW
Cash From Operating Activities -$47.59M -$82.05M -$190.9M
Capital Expenditures $21.82M -$2.430M $6.549M
Free Cash Flow -$69.41M -$79.62M -$197.5M
YoY Change -64.86% 113.29% 42.52%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2020 vir Failed Sale Leaseback Transaction Proceeds Financing Activities
FailedSaleLeasebackTransactionProceedsFinancingActivities
CY2020 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
CY2021 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
CY2020 vir Initial Fair Value Of Derivative Liability
InitialFairValueOfDerivativeLiability
CY2021 vir Proceeds From Repayment Of Promissory Notes
ProceedsFromRepaymentOfPromissoryNotes
CY2021 vir Reclassification Of Preferred Stock Warrant Liability To Additional Paid In Capital
ReclassificationOfPreferredStockWarrantLiabilityToAdditionalPaidInCapital
CY2021 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
CY2020 vir Advanced Proceeds Applied To Convertible Preferred Stock Issuance
AdvancedProceedsAppliedToConvertiblePreferredStockIssuance
CY2021 vir Cash Paid In Lieu Of Fractional Shares In Reverse Split Of Common Stock
CashPaidInLieuOfFractionalSharesInReverseSplitOfCommonStock
CY2021 vir Payment Of Contingent Consideration
PaymentOfContingentConsideration
CY2021Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesAndOtherLiabilities
CY2019 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
CY2019 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
CY2020 vir Reclassification Of Preferred Stock Warrant Liability To Additional Paid In Capital
ReclassificationOfPreferredStockWarrantLiabilityToAdditionalPaidInCapital
CY2021 vir Advanced Proceeds Applied To Convertible Preferred Stock Issuance
AdvancedProceedsAppliedToConvertiblePreferredStockIssuance
CY2021 vir Initial Fair Value Of Derivative Liability
InitialFairValueOfDerivativeLiability
CY2020 vir Cash Paid In Lieu Of Fractional Shares In Reverse Split Of Common Stock
CashPaidInLieuOfFractionalSharesInReverseSplitOfCommonStock
CY2021Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020 vir Proceeds From Repayment Of Promissory Notes
ProceedsFromRepaymentOfPromissoryNotes
CY2021 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
CY2019 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
CY2020 vir Common Stock Issued In Connection With License Agreement
CommonStockIssuedInConnectionWithLicenseAgreement
CY2020 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
CY2020Q4 us-gaap Commitments And Contingencies
CommitmentsAndContingencies
CY2020 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
CY2019 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
CY2021 vir Reclassification Of Derivative Liability To Additional Paid In Capital Upon Achievement Of Development Milestone
ReclassificationOfDerivativeLiabilityToAdditionalPaidInCapitalUponAchievementOfDevelopmentMilestone
CY2021 dei Entity Central Index Key
EntityCentralIndexKey
0001706431
CY2021 dei Amendment Flag
AmendmentFlag
false
CY2020 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
CY2020Q4 us-gaap Operating Lease Liability Current Statement Of Financial Position Extensible List
OperatingLeaseLiabilityCurrentStatementOfFinancialPositionExtensibleList
http://fasb.org/us-gaap/2021-01-31#AccruedLiabilitiesAndOtherLiabilities
CY2019 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
CY2021 vir Conversion Of Preferred Stock Into Common Stock Upon Completion Of Initial Public Offering
ConversionOfPreferredStockIntoCommonStockUponCompletionOfInitialPublicOffering
CY2019 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
CY2019 vir Increase Decrease In Payment Of Contingent Consideration In Excess Of Acquisition Date Fair Value
IncreaseDecreaseInPaymentOfContingentConsiderationInExcessOfAcquisitionDateFairValue
CY2021 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
CY2021 vir Failed Sale Leaseback Transaction Proceeds Financing Activities
FailedSaleLeasebackTransactionProceedsFinancingActivities
CY2020 vir Non Cash Common Stock Issued For Contingent Consideration
NonCashCommonStockIssuedForContingentConsideration
CY2021 dei Current Fiscal Year End Date
CurrentFiscalYearEndDate
--12-31
CY2020 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2019 vir Proceeds From Issuance Of Common Stock In Connection With Collaboration
ProceedsFromIssuanceOfCommonStockInConnectionWithCollaboration
CY2019 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
CY2019Q3 us-gaap Stockholders Equity Note Stock Split Conversion Ratio1
StockholdersEquityNoteStockSplitConversionRatio1
0.222222222
CY2019 vir Reclassification Of Derivative Liability To Additional Paid In Capital Upon Achievement Of Development Milestone
ReclassificationOfDerivativeLiabilityToAdditionalPaidInCapitalUponAchievementOfDevelopmentMilestone
CY2021 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
CY2021 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
CY2019 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
CY2020 vir Conversion Of Preferred Stock Into Common Stock Upon Completion Of Initial Public Offering
ConversionOfPreferredStockIntoCommonStockUponCompletionOfInitialPublicOffering
CY2021 dei Document Fiscal Period Focus
DocumentFiscalPeriodFocus
FY
CY2021 vir Common Stock Issued In Connection With License Agreement
CommonStockIssuedInConnectionWithLicenseAgreement
CY2019 vir Payment Of Contingent Consideration
PaymentOfContingentConsideration
CY2021 us-gaap Lessee Operating Lease Existence Of Option To Extend
LesseeOperatingLeaseExistenceOfOptionToExtend
true
CY2019 vir Non Cash Common Stock Issued For Contingent Consideration
NonCashCommonStockIssuedForContingentConsideration
CY2019 vir Noncash Lease Expense
NoncashLeaseExpense
CY2019 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
CY2021 dei Document Type
DocumentType
10-K
CY2021 dei Document Annual Report
DocumentAnnualReport
true
CY2021 dei Document Period End Date
DocumentPeriodEndDate
2021-12-31
CY2021 dei Document Fiscal Year Focus
DocumentFiscalYearFocus
2021
CY2021 dei Document Transition Report
DocumentTransitionReport
false
CY2021 dei Entity File Number
EntityFileNumber
1-39083
CY2021 dei Entity Registrant Name
EntityRegistrantName
Vir Biotechnology, Inc.
CY2021 dei Entity Incorporation State Country Code
EntityIncorporationStateCountryCode
DE
CY2021 dei Entity Tax Identification Number
EntityTaxIdentificationNumber
81-2730369
CY2021 dei Entity Address Address Line1
EntityAddressAddressLine1
499 Illinois Street, Suite 500
CY2021 dei Entity Address City Or Town
EntityAddressCityOrTown
San Francisco
CY2021 dei Entity Address State Or Province
EntityAddressStateOrProvince
CA
CY2021 dei Entity Address Postal Zip Code
EntityAddressPostalZipCode
94158
CY2021 dei City Area Code
CityAreaCode
415
CY2021 dei Local Phone Number
LocalPhoneNumber
906-4324
CY2021 dei Security12b Title
Security12bTitle
Common Stock, $0.0001 par value
CY2021 dei Trading Symbol
TradingSymbol
VIR
CY2021 dei Security Exchange Name
SecurityExchangeName
NASDAQ
CY2021 dei Entity Well Known Seasoned Issuer
EntityWellKnownSeasonedIssuer
Yes
CY2021 dei Entity Voluntary Filers
EntityVoluntaryFilers
No
CY2021 dei Entity Current Reporting Status
EntityCurrentReportingStatus
Yes
CY2021 dei Entity Interactive Data Current
EntityInteractiveDataCurrent
Yes
CY2021 dei Entity Filer Category
EntityFilerCategory
Large Accelerated Filer
CY2021 dei Entity Small Business
EntitySmallBusiness
false
CY2021 dei Entity Emerging Growth Company
EntityEmergingGrowthCompany
false
CY2021 dei Icfr Auditor Attestation Flag
IcfrAuditorAttestationFlag
true
CY2021 dei Entity Shell Company
EntityShellCompany
false
CY2021Q2 dei Entity Public Float
EntityPublicFloat
2700000000
CY2022Q1 dei Entity Common Stock Shares Outstanding
EntityCommonStockSharesOutstanding
132303561
CY2021 dei Auditor Firm
AuditorFirmId
42
CY2021 dei Auditor Name
AuditorName
Ernst & Young LLP
CY2021 dei Auditor Location
AuditorLocation
Redwood City, California
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
347815000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
436575000
CY2021Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
217182000
CY2020Q4 us-gaap Marketable Securities Current
MarketableSecuritiesCurrent
300286000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8594000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7993000
CY2021Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
773079000
CY2020Q4 us-gaap Accounts Receivable Net Current
AccountsReceivableNetCurrent
0
CY2021Q4 vir Equity Investment Current
EquityInvestmentCurrent
143148000
CY2020Q4 vir Equity Investment Current
EquityInvestmentCurrent
0
CY2021Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
73003000
CY2020Q4 us-gaap Prepaid Expense And Other Assets Current
PrepaidExpenseAndOtherAssetsCurrent
27511000
CY2021Q4 us-gaap Assets Current
AssetsCurrent
1562821000
CY2020Q4 us-gaap Assets Current
AssetsCurrent
772365000
CY2021Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33287000
CY2020Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
33820000
CY2021Q4 us-gaap Goodwill
Goodwill
16937000
CY2020Q4 us-gaap Goodwill
Goodwill
16937000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42834000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17946000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
87220000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61947000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7006000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
6919000
CY2021Q4 us-gaap Long Term Investments
LongTermInvestments
201388000
CY2020Q4 us-gaap Long Term Investments
LongTermInvestments
0
CY2021Q4 us-gaap Other Assets
OtherAssets
2775000
CY2020Q4 us-gaap Other Assets
OtherAssets
8827000
CY2021Q4 us-gaap Assets
Assets
1954268000
CY2020Q4 us-gaap Assets
Assets
918761000
CY2021Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
6521000
CY2020Q4 us-gaap Accounts Payable Current
AccountsPayableCurrent
5077000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
236512000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
76936000
CY2021Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
98209000
CY2020Q4 us-gaap Deferred Revenue Current
DeferredRevenueCurrent
6451000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
0
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Current
BusinessCombinationContingentConsiderationLiabilityCurrent
10600000
CY2021Q4 us-gaap Liabilities Current
LiabilitiesCurrent
341242000
CY2020Q4 us-gaap Liabilities Current
LiabilitiesCurrent
99064000
CY2021Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3815000
CY2020Q4 us-gaap Deferred Revenue Noncurrent
DeferredRevenueNoncurrent
3815000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
133561000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
66556000
CY2021Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
22822000
CY2020Q4 us-gaap Business Combination Contingent Consideration Liability Noncurrent
BusinessCombinationContingentConsiderationLiabilityNoncurrent
25374000
CY2021Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
18439000
CY2020Q4 us-gaap Deferred Income Tax Liabilities Net
DeferredIncomeTaxLiabilitiesNet
3253000
CY2021Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
2540000
CY2020Q4 us-gaap Other Liabilities Noncurrent
OtherLiabilitiesNoncurrent
3847000
CY2020 us-gaap Revenues
Revenues
76368000
CY2019 us-gaap Revenues
Revenues
8091000
CY2021 us-gaap Cost Of Revenue
CostOfRevenue
65865000
CY2020 us-gaap Cost Of Revenue
CostOfRevenue
0
CY2019 us-gaap Cost Of Revenue
CostOfRevenue
0
CY2021 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
448006000
CY2020 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
302411000
CY2021Q4 us-gaap Liabilities
Liabilities
522419000
CY2020Q4 us-gaap Liabilities
Liabilities
201909000
CY2021Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Preferred Stock Par Or Stated Value Per Share
PreferredStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Authorized
PreferredStockSharesAuthorized
10000000
CY2020Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2020Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Shares Issued
PreferredStockSharesIssued
0
CY2021Q4 us-gaap Preferred Stock Shares Outstanding
PreferredStockSharesOutstanding
0
CY2021Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2020Q4 us-gaap Preferred Stock Value
PreferredStockValue
0
CY2021Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2020Q4 us-gaap Common Stock Par Or Stated Value Per Share
CommonStockParOrStatedValuePerShare
0.0001
CY2021Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2020Q4 us-gaap Common Stock Shares Authorized
CommonStockSharesAuthorized
300000000
CY2021Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
131161404
CY2021Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
131161404
CY2020Q4 us-gaap Common Stock Shares Issued
CommonStockSharesIssued
127416740
CY2020Q4 us-gaap Common Stock Shares Outstanding
CommonStockSharesOutstanding
127416740
CY2021Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2020Q4 us-gaap Common Stock Value
CommonStockValue
13000
CY2021Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1571535000
CY2020Q4 us-gaap Additional Paid In Capital
AdditionalPaidInCapital
1385301000
CY2021Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1099000
CY2020Q4 us-gaap Accumulated Other Comprehensive Income Loss Net Of Tax
AccumulatedOtherComprehensiveIncomeLossNetOfTax
-1278000
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-138600000
CY2020Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-667184000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1431849000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
716852000
CY2021Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
1954268000
CY2020Q4 us-gaap Liabilities And Stockholders Equity
LiabilitiesAndStockholdersEquity
918761000
CY2021 us-gaap Revenues
Revenues
1095415000
CY2019 us-gaap Research And Development Expense
ResearchAndDevelopmentExpense
148472000
CY2021 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
160793000
CY2020 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
70937000
CY2019 us-gaap Selling General And Administrative Expense
SellingGeneralAndAdministrativeExpense
37598000
CY2021 us-gaap Costs And Expenses
CostsAndExpenses
674664000
CY2020 us-gaap Costs And Expenses
CostsAndExpenses
373348000
CY2019 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
8511000
CY2021 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-9437000
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119159424
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30349920
CY2021 us-gaap Net Income Loss
NetIncomeLoss
528584000
CY2019 us-gaap Costs And Expenses
CostsAndExpenses
186070000
CY2021 us-gaap Operating Income Loss
OperatingIncomeLoss
420751000
CY2020 us-gaap Operating Income Loss
OperatingIncomeLoss
-296980000
CY2019 us-gaap Operating Income Loss
OperatingIncomeLoss
-177979000
CY2021 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
138049000
CY2020 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0
CY2019 us-gaap Equity Securities Fv Ni Unrealized Gain Loss
EquitySecuritiesFvNiUnrealizedGainLoss
0
CY2021 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
439000
CY2020 us-gaap Investment Income Net Amortization Of Discount And Premium
InvestmentIncomeNetAmortizationOfDiscountAndPremium
2836000
CY2020 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-4467000
CY2019 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-5061000
CY2021 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
129051000
CY2020 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
1631000
CY2019 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-3450000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
549802000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-298611000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-174529000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21218000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
154000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
528584000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-298665000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-174683000
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.07
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.51
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.76
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.96
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.51
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.76
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129884967
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119159424
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30349920
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133437126
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-298665000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-174683000
CY2021 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-957000
CY2020 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
-50000
CY2019 us-gaap Other Comprehensive Income Unrealized Holding Gain Loss On Securities Arising During Period Net Of Tax
OtherComprehensiveIncomeUnrealizedHoldingGainLossOnSecuritiesArisingDuringPeriodNetOfTax
149000
CY2021 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-55000
CY2020 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
-23000
CY2019 us-gaap Other Comprehensive Income Loss Reclassification Adjustment From Aoci Pension And Other Postretirement Benefit Plans For Net Gain Loss Net Of Tax
OtherComprehensiveIncomeLossReclassificationAdjustmentFromAOCIPensionAndOtherPostretirementBenefitPlansForNetGainLossNetOfTax
0
CY2021 vir Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment To Projected Benefit Obligations Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentToProjectedBenefitObligationsNetOfTax
-1081000
CY2020 vir Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment To Projected Benefit Obligations Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentToProjectedBenefitObligationsNetOfTax
650000
CY2019 vir Other Comprehensive Income Loss Pension And Other Postretirement Benefit Plans Adjustment To Projected Benefit Obligations Net Of Tax
OtherComprehensiveIncomeLossPensionAndOtherPostretirementBenefitPlansAdjustmentToProjectedBenefitObligationsNetOfTax
736000
CY2021 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
244000
CY2020 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
-1548000
CY2019 us-gaap Accretion Amortization Of Discounts And Premiums Investments
AccretionAmortizationOfDiscountsAndPremiumsInvestments
179000
CY2019 us-gaap Adjustments To Additional Paid In Capital Stock Split
AdjustmentsToAdditionalPaidInCapitalStockSplit
3000
CY2019 vir Stock Issued During Period Value License Agreement
StockIssuedDuringPeriodValueLicenseAgreement
617000
CY2019 vir Stock Issued During Period Repayment Of Promissory Notes Net Of Unvested Common Stock Value
StockIssuedDuringPeriodRepaymentOfPromissoryNotesNetOfUnvestedCommonStockValue
1355000
CY2019 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
476000
CY2019 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
1129000
CY2019 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
8719000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-587000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-174683000
CY2019Q4 us-gaap Stockholders Equity
StockholdersEquity
423942000
CY2021 vir Noncash Lease Expense
NoncashLeaseExpense
6172000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
179000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-677000
CY2019 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-587000
CY2021 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
528763000
CY2020 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-299342000
CY2019 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-175270000
CY2018Q4 us-gaap Stockholders Equity
StockholdersEquity
-179177000
CY2019 us-gaap Stock Issued During Period Value Conversion Of Convertible Securities
StockIssuedDuringPeriodValueConversionOfConvertibleSecurities
636612000
CY2019 vir Initial Public Offering Costs
InitialPublicOfferingCosts
16446000
CY2019 vir Reclassification Of Warrant Liability To Additional Paid In Capital
ReclassificationOfWarrantLiabilityToAdditionalPaidInCapital
3073000
CY2020 vir Reclassification Of Derivative Liability To Additional Paid In Capital
ReclassificationOfDerivativeLiabilityToAdditionalPaidInCapital
29245000
CY2020 vir Stock Issued During Period Value Collaboration Agreement
StockIssuedDuringPeriodValueCollaborationAgreement
206699000
CY2020 vir Common Stock Issuance Cost
CommonStockIssuanceCost
21786000
CY2020 us-gaap Stock Issued During Period Value Restricted Stock Award Gross
StockIssuedDuringPeriodValueRestrictedStockAwardGross
1435000
CY2020 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
4059000
CY2020 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
27600000
CY2020 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
-677000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-298665000
CY2020Q4 us-gaap Stockholders Equity
StockholdersEquity
716852000
CY2021 vir Stock Issued During Period Value Collaboration Agreement
StockIssuedDuringPeriodValueCollaborationAgreement
85213000
CY2021 vir Stock Issued During Period Value Issued For Settlement Of Contingent Consideration
StockIssuedDuringPeriodValueIssuedForSettlementOfContingentConsideration
1860000
CY2021 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
13077000
CY2021 us-gaap Stock Issued During Period Value Employee Stock Purchase Plan
StockIssuedDuringPeriodValueEmployeeStockPurchasePlan
2300000
CY2021 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
83784000
CY2021 us-gaap Other Comprehensive Income Loss Net Of Tax Portion Attributable To Parent
OtherComprehensiveIncomeLossNetOfTaxPortionAttributableToParent
179000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
528584000
CY2021Q4 us-gaap Stockholders Equity
StockholdersEquity
1431849000
CY2021 us-gaap Profit Loss
ProfitLoss
528584000
CY2020 us-gaap Profit Loss
ProfitLoss
-298665000
CY2019 us-gaap Profit Loss
ProfitLoss
-174683000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5278000
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4400000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3294000
CY2021 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
533000
CY2020 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1042000
CY2019 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
1223000
CY2020 us-gaap Impairment Of Intangible Assets Finitelived
ImpairmentOfIntangibleAssetsFinitelived
832000
CY2020 vir Noncash Lease Expense
NoncashLeaseExpense
3371000
CY2020 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
38394000
CY2019 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
643898000
CY2021 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
301243000
CY2020 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
400348000
CY2019 us-gaap Proceeds From Sale Maturity And Collections Of Investments
ProceedsFromSaleMaturityAndCollectionsOfInvestments
396680000
CY2020 us-gaap Proceeds From Sale Of Machinery And Equipment
ProceedsFromSaleOfMachineryAndEquipment
180000
CY2021 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-140814000
CY2021 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
91848000
CY2019 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
345000
CY2021 us-gaap Assets Fair Value Adjustment
AssetsFairValueAdjustment
-138049000
CY2019 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
8330000
CY2021 vir Increase Decrease In Payment Of Contingent Consideration In Excess Of Acquisition Date Fair Value
IncreaseDecreaseInPaymentOfContingentConsiderationInExcessOfAcquisitionDateFairValue
-8140000
CY2020 vir Increase Decrease In Payment Of Contingent Consideration In Excess Of Acquisition Date Fair Value
IncreaseDecreaseInPaymentOfContingentConsiderationInExcessOfAcquisitionDateFairValue
-15752000
CY2019 vir Initial Fair Value Of Derivative Liability
InitialFairValueOfDerivativeLiability
13599000
CY2020 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
-16796000
CY2019 us-gaap Derivative Gain Loss On Derivative Net
DerivativeGainLossOnDerivativeNet
1150000
CY2019 us-gaap Fair Value Adjustment Of Warrants
FairValueAdjustmentOfWarrants
2049000
CY2021 us-gaap Share Based Compensation
ShareBasedCompensation
83784000
CY2020 us-gaap Share Based Compensation
ShareBasedCompensation
27600000
CY2019 us-gaap Share Based Compensation
ShareBasedCompensation
8719000
CY2021 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-15186000
CY2020 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
52000
CY2021 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
4844000
CY2019 vir Common Stock Issued In Connection With License Agreement
CommonStockIssuedInConnectionWithLicenseAgreement
617000
CY2021 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
697000
CY2020 us-gaap Other Operating Activities Cash Flow Statement
OtherOperatingActivitiesCashFlowStatement
23000
CY2021 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
773079000
CY2021 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
3665000
CY2020 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4475000
CY2019 us-gaap Increase Decrease In Prepaid Deferred Expense And Other Assets
IncreaseDecreaseInPrepaidDeferredExpenseAndOtherAssets
4619000
CY2021 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1483000
CY2020 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1100000
CY2019 us-gaap Increase Decrease In Other Operating Assets
IncreaseDecreaseInOtherOperatingAssets
1881000
CY2021 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-171000
CY2020 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
-790000
CY2019 us-gaap Increase Decrease In Accounts Payable
IncreaseDecreaseInAccountsPayable
964000
CY2021 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
58498000
CY2020 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
46614000
CY2019 us-gaap Increase Decrease In Accrued Liabilities And Other Operating Liabilities
IncreaseDecreaseInAccruedLiabilitiesAndOtherOperatingLiabilities
10211000
CY2021 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-535000
CY2020 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-3684000
CY2021 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
92041000
CY2020 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-7043000
CY2019 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
3529000
CY2021 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-47589000
CY2020 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-190941000
CY2019 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
-129632000
CY2021 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
21817000
CY2020 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
6549000
CY2019 us-gaap Payments To Acquire Property Plant And Equipment
PaymentsToAcquirePropertyPlantAndEquipment
8940000
CY2021 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
420240000
CY2020 us-gaap Payments To Acquire Investments
PaymentsToAcquireInvestments
403841000
CY2020 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
323214000
CY2019 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
126411000
CY2021 vir Proceeds From Issuance Of Common Stock In Connection With Collaboration
ProceedsFromIssuanceOfCommonStockInConnectionWithCollaboration
85213000
CY2021 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-88072000
CY2020 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-9862000
CY2019 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-256158000
CY2020 vir Proceeds From Issuance Of Common Stock In Connection With Collaboration
ProceedsFromIssuanceOfCommonStockInConnectionWithCollaboration
206699000
CY2019 us-gaap Proceeds From Issuance Of Convertible Preferred Stock
ProceedsFromIssuanceOfConvertiblePreferredStock
317335000
CY2019 vir Failed Sale Leaseback Transaction Proceeds Financing Activities
FailedSaleLeasebackTransactionProceedsFinancingActivities
1202000
CY2020 vir Payment Of Contingent Consideration
PaymentOfContingentConsideration
4248000
CY2021 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
259000
CY2020 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
250000
CY2019 us-gaap Finance Lease Principal Payments
FinanceLeasePrincipalPayments
95000
CY2019 vir Proceeds From Repayment Of Promissory Notes
ProceedsFromRepaymentOfPromissoryNotes
3265000
CY2021 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
13077000
CY2020 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
4059000
CY2019 us-gaap Proceeds From Stock Options Exercised
ProceedsFromStockOptionsExercised
1129000
CY2021 us-gaap Proceeds From Stock Plans
ProceedsFromStockPlans
2300000
CY2019 vir Cash Paid In Lieu Of Fractional Shares In Reverse Split Of Common Stock
CashPaidInLieuOfFractionalSharesInReverseSplitOfCommonStock
3000
CY2021 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
100331000
CY2020 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
529474000
CY2019 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
449244000
CY2020 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
328671000
CY2019 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
63454000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
451487000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122816000
CY2018Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
59362000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
363415000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
451487000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122816000
CY2021 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
8731000
CY2020 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
382000
CY2019 us-gaap Capital Expenditures Incurred But Not Yet Paid
CapitalExpendituresIncurredButNotYetPaid
892000
CY2021 vir Non Cash Common Stock Issued For Contingent Consideration
NonCashCommonStockIssuedForContingentConsideration
1860000
CY2019 vir Conversion Of Preferred Stock Into Common Stock Upon Completion Of Initial Public Offering
ConversionOfPreferredStockIntoCommonStockUponCompletionOfInitialPublicOffering
636612000
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
77187000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
48495000
CY2019 vir Advanced Proceeds Applied To Convertible Preferred Stock Issuance
AdvancedProceedsAppliedToConvertiblePreferredStockIssuance
10140000
CY2020 vir Reclassification Of Derivative Liability To Additional Paid In Capital Upon Achievement Of Development Milestone
ReclassificationOfDerivativeLiabilityToAdditionalPaidInCapitalUponAchievementOfDevelopmentMilestone
29245000
CY2019 vir Reclassification Of Preferred Stock Warrant Liability To Additional Paid In Capital
ReclassificationOfPreferredStockWarrantLiabilityToAdditionalPaidInCapital
3073000
CY2021Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
347815000
CY2020Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
436575000
CY2019Q4 us-gaap Cash And Cash Equivalents At Carrying Value
CashAndCashEquivalentsAtCarryingValue
109335000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
8594000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
7993000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents At Carrying Value
RestrictedCashAndCashEquivalentsAtCarryingValue
6181000
CY2021Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7006000
CY2020Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
6919000
CY2019Q4 us-gaap Restricted Cash And Cash Equivalents Noncurrent
RestrictedCashAndCashEquivalentsNoncurrent
7300000
CY2021Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
363415000
CY2020Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
451487000
CY2019Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
122816000
CY2019Q4 us-gaap Proceeds From Issuance Initial Public Offering
ProceedsFromIssuanceInitialPublicOffering
126400000
CY2020Q4 vir Sale Of Stock Consideration Aggregate Offering Price
SaleOfStockConsiderationAggregateOfferingPrice
300000000.0
CY2021Q4 us-gaap Retained Earnings Accumulated Deficit
RetainedEarningsAccumulatedDeficit
-138600000
CY2021Q4 us-gaap Cash Cash Equivalents And Short Term Investments
CashCashEquivalentsAndShortTermInvestments
909500000
CY2021Q4 vir Cash Cash Equivalents And Short Term Investments Excluding Equity Investment
CashCashEquivalentsAndShortTermInvestmentsExcludingEquityInvestment
766400000
CY2021Q4 vir Cash Cash Equivalents And Short Term Investments Excluding Equity Investment
CashCashEquivalentsAndShortTermInvestmentsExcludingEquityInvestment
766400000
CY2021 us-gaap Use Of Estimates
UseOfEstimates
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Use of Estimates</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;"> </span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The preparation of the consolidated financial statements in conformity with GAAP requires management to make estimates and assumptions that affect the reported amounts of assets and liabilities and disclosure of contingent liabilities at the date of the consolidated financial statements and the reported amounts of revenue and expense during the reporting periods. The Company evaluates its estimates and assumptions on an ongoing basis using historical experience and other factors and adjusts those estimates and assumptions when facts and circumstances dictate. Actual results could materially differ from those estimates.</span><span style="color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;"> </span></p>
CY2021Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7502000
CY2020Q4 us-gaap Finite Lived Intangible Assets Gross
FiniteLivedIntangibleAssetsGross
7502000
CY2021Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
4114000
CY2021 us-gaap Number Of Operating Segments
NumberOfOperatingSegments
1
CY2021Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2020Q4 us-gaap Debt Securities Available For Sale Allowance For Credit Loss
DebtSecuritiesAvailableForSaleAllowanceForCreditLoss
0
CY2021 us-gaap Property Plant And Equipment Estimated Useful Lives
PropertyPlantAndEquipmentEstimatedUsefulLives
Depreciation and amortization are computed using the straight-line method over the estimated useful lives of the respective assets, generally three to five years.
CY2020Q4 us-gaap Finite Lived Intangible Assets Accumulated Amortization
FiniteLivedIntangibleAssetsAccumulatedAmortization
3581000
CY2021Q4 vir Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
832000
CY2021 us-gaap Impairment Of Intangible Assets Indefinitelived Excluding Goodwill
ImpairmentOfIntangibleAssetsIndefinitelivedExcludingGoodwill
0
CY2021 us-gaap Finite Lived Intangible Assets Amortization Method
FiniteLivedIntangibleAssetsAmortizationMethod
Amortization is computed using the straight-line method over the estimated useful lives of the respective finite-lived intangible assets, generally seven to 15 years.
CY2020Q4 vir Finite Lived Intangible Assets Accumulated Impairment
FiniteLivedIntangibleAssetsAccumulatedImpairment
832000
CY2021Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
2556000
CY2021 us-gaap Derivatives Embedded Derivatives
DerivativesEmbeddedDerivatives
<p style="text-indent:0.0%;font-size:10.0pt;margin-top:18.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:bold;font-size:10.0pt;font-family:Times New Roman;font-style:italic;">Embedded Derivatives</span></p><p style="text-indent:4.533%;font-size:10.0pt;margin-top:6.0pt;line-height:1.15;font-family:Times New Roman;margin-bottom:0.0pt;text-align:left;"><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">The Company evaluates its acquisitions, collaborative arrangements and other business development transactions to determine if embedded components of these contracts meet the definition of a derivative under ASC 815, Derivatives and Hedging. In general, embedded derivatives are required to be bifurcated from the host instrument if (i) the embedded feature is not clearly and closely related to the host contract and (ii) the embedded feature, if considered a freestanding instrument, meets the definition of a derivative. Embedded derivatives are reported on the consolidated balance sheets at their estimated fair values. Contingent consideration related to asset acquisitions that meet the definition of an embedded derivative is classified as contingent consideration on the consolidated balance sheets. Any change in estimated fair values, as determined at each measurement period, are recorded in the consolidated statements of operations based on the nature of the related contingencies.</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:8.0pt;font-family:Times New Roman;"> </span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">Changes in fair values of embedded derivatives related to the achievement of various milestones for product candidates are recorded within research and development expense or selling, general and administrative expenses based on the nature of the relevant underlying activities</span><span style="background-color:rgba(0,0,0,0);color:rgba(0,0,0,1);white-space:pre-wrap;font-weight:normal;font-size:10.0pt;font-family:Times New Roman;">. Otherwise, changes in fair values are recorded within other income (expense), net.</span></p>
CY2021Q4 vir Financial Assets Amortized Cost Basis
FinancialAssetsAmortizedCostBasis
764540000
CY2021Q4 vir Financial Assets Gross Unrealized Holding Gains
FinancialAssetsGrossUnrealizedHoldingGains
0
CY2021Q4 vir Financial Assets Gross Unrealized Holding Losses
FinancialAssetsGrossUnrealizedHoldingLosses
872000
CY2021Q4 vir Financial Assets Fair Value
FinancialAssetsFairValue
763668000
CY2020Q4 vir Financial Assets Amortized Cost Basis
FinancialAssetsAmortizedCostBasis
722036000
CY2020Q4 vir Financial Assets Gross Unrealized Holding Gains
FinancialAssetsGrossUnrealizedHoldingGains
91000
CY2020Q4 vir Financial Assets Gross Unrealized Holding Losses
FinancialAssetsGrossUnrealizedHoldingLosses
6000
CY2020Q4 vir Financial Assets Fair Value
FinancialAssetsFairValue
722121000
CY2021 us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
0
CY2020 us-gaap Financing Receivable Accrued Interest Writeoff
FinancingReceivableAccruedInterestWriteoff
0
CY2021 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
900000
CY2020 us-gaap Debt Securities Available For Sale Unrealized Gain Loss
DebtSecuritiesAvailableForSaleUnrealizedGainLoss
100000
CY2021 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
5300000
CY2020Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
17946000
CY2021Q4 us-gaap Goodwill
Goodwill
16900000
CY2021 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0
CY2020 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
4400000
CY2019 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
3300000
CY2021Q4 vir Milestone Payable
MilestonePayable
95000000
CY2020Q4 vir Milestone Payable
MilestonePayable
0
CY2020Q4 us-gaap Finite Lived Intangible Assets Net
FiniteLivedIntangibleAssetsNet
3089000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
532000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
532000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
260000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
213000
CY2021Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
213000
CY2021Q4 vir Finite Lived Intangible Assets Amortization Expense
FiniteLivedIntangibleAssetsAmortizationExpense
1750000
CY2020Q4 vir Finite Lived Intangible Assets Reclassified From Indefinite Lived
FiniteLivedIntangibleAssetsReclassifiedFromIndefiniteLived
500000
CY2021Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
57326000
CY2020Q4 us-gaap Property Plant And Equipment Gross
PropertyPlantAndEquipmentGross
27178000
CY2021Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
14492000
CY2020Q4 us-gaap Accumulated Depreciation Depletion And Amortization Property Plant And Equipment
AccumulatedDepreciationDepletionAndAmortizationPropertyPlantAndEquipment
9232000
CY2021Q4 us-gaap Property Plant And Equipment Net
PropertyPlantAndEquipmentNet
42834000
CY2021Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
58672000
CY2020Q4 us-gaap Accrued Royalties Current
AccruedRoyaltiesCurrent
0
CY2021 vir Lease Arrangement Contractual Expiration Ending Year
LeaseArrangementContractualExpirationEndingYear
2033
CY2021 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
77187000
CY2020 us-gaap Right Of Use Asset Obtained In Exchange For Operating Lease Liability
RightOfUseAssetObtainedInExchangeForOperatingLeaseLiability
48495000
CY2021Q4 vir Research And Development Expenses Current
ResearchAndDevelopmentExpensesCurrent
28073000
CY2020Q4 vir Research And Development Expenses Current
ResearchAndDevelopmentExpensesCurrent
49384000
CY2021Q4 vir Payroll And Related Expenses Current
PayrollAndRelatedExpensesCurrent
29753000
CY2020Q4 vir Payroll And Related Expenses Current
PayrollAndRelatedExpensesCurrent
17060000
CY2021Q4 us-gaap Accrued Income Taxes Current
AccruedIncomeTaxesCurrent
6217000
CY2021Q4 vir Excess Funds Payable Under Grant Agreements Current
ExcessFundsPayableUnderGrantAgreementsCurrent
1825000
CY2020Q4 vir Excess Funds Payable Under Grant Agreements Current
ExcessFundsPayableUnderGrantAgreementsCurrent
3467000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3927000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3625000
CY2021Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2791000
CY2020Q4 us-gaap Accrued Professional Fees Current
AccruedProfessionalFeesCurrent
2595000
CY2021Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
10254000
CY2020Q4 us-gaap Other Accrued Liabilities Current
OtherAccruedLiabilitiesCurrent
805000
CY2021Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
236512000
CY2020Q4 us-gaap Accrued Liabilities And Other Liabilities
AccruedLiabilitiesAndOtherLiabilities
76936000
CY2021 vir Lease Arrangement Contractual Expiration Beginning Year
LeaseArrangementContractualExpirationBeginningYear
2022
CY2021 us-gaap Lessee Operating Lease Option To Extend
LesseeOperatingLeaseOptionToExtend
These leases require monthly lease payments that may be subject to annual increases throughout the lease term. Certain lease agreements also provide the Company with the option to renew for additional periods ranging from one to five years.
CY2021Q4 vir Tenant Improvement Allowance Aggregate
TenantImprovementAllowanceAggregate
14700000
CY2021 us-gaap Gain Loss On Termination Of Lease
GainLossOnTerminationOfLease
4800000
CY2021Q4 vir Tenant Improvement Allowance Aggregate
TenantImprovementAllowanceAggregate
37500000
CY2021 us-gaap Operating Lease Cost
OperatingLeaseCost
11921000
CY2020 us-gaap Operating Lease Cost
OperatingLeaseCost
4591000
CY2021 us-gaap Short Term Lease Cost
ShortTermLeaseCost
261000
CY2020 us-gaap Short Term Lease Cost
ShortTermLeaseCost
459000
CY2021 us-gaap Variable Lease Cost
VariableLeaseCost
4256000
CY2020 us-gaap Variable Lease Cost
VariableLeaseCost
2299000
CY2021 us-gaap Lease Cost
LeaseCost
16438000
CY2020 us-gaap Lease Cost
LeaseCost
7349000
CY2021Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y4M24D
CY2020Q4 us-gaap Operating Lease Weighted Average Remaining Lease Term1
OperatingLeaseWeightedAverageRemainingLeaseTerm1
P10Y7M6D
CY2021Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.052
CY2020Q4 us-gaap Operating Lease Weighted Average Discount Rate Percent
OperatingLeaseWeightedAverageDiscountRatePercent
0.077
CY2021 us-gaap Operating Lease Payments
OperatingLeasePayments
6250000
CY2020 us-gaap Operating Lease Payments
OperatingLeasePayments
5081000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Next Twelve Months
LesseeOperatingLeaseLiabilityPaymentsDueNextTwelveMonths
12432000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Two
LesseeOperatingLeaseLiabilityPaymentsDueYearTwo
19082000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Three
LesseeOperatingLeaseLiabilityPaymentsDueYearThree
18233000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Four
LesseeOperatingLeaseLiabilityPaymentsDueYearFour
15917000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due Year Five
LesseeOperatingLeaseLiabilityPaymentsDueYearFive
16353000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due After Year Five
LesseeOperatingLeaseLiabilityPaymentsDueAfterYearFive
103413000
CY2021Q4 us-gaap Lessee Operating Lease Liability Payments Due
LesseeOperatingLeaseLiabilityPaymentsDue
185430000
CY2021Q4 us-gaap Lessee Operating Lease Liability Undiscounted Excess Amount
LesseeOperatingLeaseLiabilityUndiscountedExcessAmount
45261000
CY2021Q4 vir Lessee Operating Lease Liability Net Tenant Improvement Allowance Yet To Be Received
LesseeOperatingLeaseLiabilityNetTenantImprovementAllowanceYetToBeReceived
52217000
CY2021Q4 vir Present Value Of Operating Lease Liabilities
PresentValueOfOperatingLeaseLiabilities
87952000
CY2021Q4 vir Operating Lease Incentive Over Lease Liabilities
OperatingLeaseIncentiveOverLeaseLiabilities
49536000
CY2020Q4 vir Operating Lease Incentive Over Lease Liabilities
OperatingLeaseIncentiveOverLeaseLiabilities
7913000
CY2021Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
87220000
CY2020Q4 us-gaap Operating Lease Right Of Use Asset
OperatingLeaseRightOfUseAsset
61947000
CY2021Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3927000
CY2020Q4 us-gaap Operating Lease Liability Current
OperatingLeaseLiabilityCurrent
3625000
CY2021Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
133561000
CY2020Q4 us-gaap Operating Lease Liability Noncurrent
OperatingLeaseLiabilityNoncurrent
66556000
CY2021Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
137488000
CY2020Q4 us-gaap Operating Lease Liability
OperatingLeaseLiability
70181000
CY2019 vir Operating And Finance Rent Expense
OperatingAndFinanceRentExpense
4400000
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2021Q4 vir Number Of Class Of Stock
NumberOfClassOfStock
2
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2016Q3 us-gaap Warrants And Rights Outstanding Maturity Date
WarrantsAndRightsOutstandingMaturityDate
2026-09-11
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
1.031
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.121
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.888
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
1.086
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMinimum
0.865
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Volatility Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedVolatilityRateMaximum
0.894
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.006
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.013
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.003
CY2020 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.012
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Minimum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMinimum
0.015
CY2019 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Risk Free Interest Rate Maximum
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsRiskFreeInterestRateMaximum
0.025
CY2021 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Fair Value Assumptions Expected Dividend Rate
ShareBasedCompensationArrangementByShareBasedPaymentAwardFairValueAssumptionsExpectedDividendRate
0
CY2020 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
119159424
CY2019 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
30349920
CY2021 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
83784000
CY2020 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
27600000
CY2019 us-gaap Allocated Share Based Compensation Expense
AllocatedShareBasedCompensationExpense
8719000
CY2021 us-gaap Net Income Loss
NetIncomeLoss
528584000
CY2020 us-gaap Net Income Loss
NetIncomeLoss
-298665000
CY2019 us-gaap Net Income Loss
NetIncomeLoss
-174683000
CY2021 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
129884967
CY2020 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
119159424
CY2019 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
30349920
CY2021 us-gaap Incremental Common Shares Attributable To Share Based Payment Arrangements
IncrementalCommonSharesAttributableToShareBasedPaymentArrangements
3513438
CY2021 vir Incremental Common Shares Attributable To Dilutive Effect Of Restricted Share Subject To Future Vesting
IncrementalCommonSharesAttributableToDilutiveEffectOfRestrictedShareSubjectToFutureVesting
35488
CY2021 us-gaap Incremental Common Shares Attributable To Contingently Issuable Shares
IncrementalCommonSharesAttributableToContingentlyIssuableShares
3233
CY2021 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
133437126
CY2021 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
4.07
CY2020 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-2.51
CY2019 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-5.76
CY2021 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
3.96
CY2020 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-2.51
CY2019 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-5.76
CY2021 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
6852612
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
549802000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-298611000
CY2020 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9887543
CY2019 us-gaap Antidilutive Securities Excluded From Computation Of Earnings Per Share Amount
AntidilutiveSecuritiesExcludedFromComputationOfEarningsPerShareAmount
9506253
CY2021 vir Estimated Shares Employee Stock Purchase Plans
EstimatedSharesEmployeeStockPurchasePlans
65967
CY2021 vir Espp Discounted Purchase Price Percentage
EsppDiscountedPurchasePricePercentage
0.85
CY2021 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
2700000
CY2020 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1800000
CY2019 us-gaap Defined Contribution Plan Cost Recognized
DefinedContributionPlanCostRecognized
1200000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
535989000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-309697000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Domestic
IncomeLossFromContinuingOperationsBeforeIncomeTaxesDomestic
-138724000
CY2021 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
13813000
CY2020 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
11086000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Foreign
IncomeLossFromContinuingOperationsBeforeIncomeTaxesForeign
-35805000
CY2019 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-174529000
CY2021 us-gaap Current Federal Tax Expense Benefit
CurrentFederalTaxExpenseBenefit
3526000
CY2021 us-gaap Current State And Local Tax Expense Benefit
CurrentStateAndLocalTaxExpenseBenefit
105000
CY2021 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
2401000
CY2020 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
106000
CY2019 us-gaap Current Foreign Tax Expense Benefit
CurrentForeignTaxExpenseBenefit
154000
CY2021 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
6032000
CY2020 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
106000
CY2019 us-gaap Current Income Tax Expense Benefit
CurrentIncomeTaxExpenseBenefit
154000
CY2021 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
15186000
CY2020 us-gaap Deferred Federal Income Tax Expense Benefit
DeferredFederalIncomeTaxExpenseBenefit
-21000
CY2020 us-gaap Deferred State And Local Income Tax Expense Benefit
DeferredStateAndLocalIncomeTaxExpenseBenefit
-31000
CY2021 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
15186000
CY2020 us-gaap Deferred Income Tax Expense Benefit
DeferredIncomeTaxExpenseBenefit
-52000
CY2021 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
21218000
CY2020 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
54000
CY2019 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
154000
CY2021 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2020Q4 vir Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
-16147000
CY2021Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2422000
CY2020Q4 us-gaap Deferred Tax Liabilities Property Plant And Equipment
DeferredTaxLiabilitiesPropertyPlantAndEquipment
2570000
CY2021Q4 vir Deferred Tax Liabilities In Process Research And Development
DeferredTaxLiabilitiesInProcessResearchAndDevelopment
-8511000
CY2020Q4 vir Deferred Tax Liabilities In Process Research And Development
DeferredTaxLiabilitiesInProcessResearchAndDevelopment
-8511000
CY2020 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2019 us-gaap Effective Income Tax Rate Reconciliation At Federal Statutory Income Tax Rate
EffectiveIncomeTaxRateReconciliationAtFederalStatutoryIncomeTaxRate
0.210
CY2021 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.002
CY2020 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
0.009
CY2019 us-gaap Effective Income Tax Rate Reconciliation Foreign Income Tax Rate Differential
EffectiveIncomeTaxRateReconciliationForeignIncomeTaxRateDifferential
-0.003
CY2020 us-gaap Effective Income Tax Rate Reconciliation Prior Year Income Taxes
EffectiveIncomeTaxRateReconciliationPriorYearIncomeTaxes
-0.019
CY2021 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.007
CY2020 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.027
CY2019 us-gaap Effective Income Tax Rate Reconciliation State And Local Income Taxes
EffectiveIncomeTaxRateReconciliationStateAndLocalIncomeTaxes
0.024
CY2021 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
0.016
CY2020 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.018
CY2019 us-gaap Effective Income Tax Rate Reconciliation Tax Credits Research
EffectiveIncomeTaxRateReconciliationTaxCreditsResearch
-0.020
CY2021 vir Effective Income Tax Rate Reconciliation Permanent Items Percent
EffectiveIncomeTaxRateReconciliationPermanentItemsPercent
0.018
CY2020 vir Effective Income Tax Rate Reconciliation Permanent Items Percent
EffectiveIncomeTaxRateReconciliationPermanentItemsPercent
0.013
CY2019 vir Effective Income Tax Rate Reconciliation Permanent Items Percent
EffectiveIncomeTaxRateReconciliationPermanentItemsPercent
-0.008
CY2021 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.179
CY2020 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.253
CY2019 us-gaap Effective Income Tax Rate Reconciliation Change In Deferred Tax Assets Valuation Allowance
EffectiveIncomeTaxRateReconciliationChangeInDeferredTaxAssetsValuationAllowance
-0.243
CY2021 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
0.001
CY2020 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.005
CY2019 us-gaap Effective Income Tax Rate Reconciliation Other Adjustments
EffectiveIncomeTaxRateReconciliationOtherAdjustments
-0.001
CY2021 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.039
CY2020 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
0.000
CY2019 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.001
CY2021Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
15030000
CY2020Q4 us-gaap Deferred Tax Assets Operating Loss Carryforwards
DeferredTaxAssetsOperatingLossCarryforwards
117433000
CY2021Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
11375000
CY2020Q4 us-gaap Deferred Tax Assets Tax Credit Carryforwards Research
DeferredTaxAssetsTaxCreditCarryforwardsResearch
12246000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
15065000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Compensation And Benefits Share Based Compensation Cost
DeferredTaxAssetsTaxDeferredExpenseCompensationAndBenefitsShareBasedCompensationCost
4193000
CY2021Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
7115000
CY2020Q4 us-gaap Deferred Tax Assets Tax Deferred Expense Reserves And Accruals
DeferredTaxAssetsTaxDeferredExpenseReservesAndAccruals
10804000
CY2021Q4 vir Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
28612000
CY2020Q4 vir Deferred Tax Assets Lease Liabilities
DeferredTaxAssetsLeaseLiabilities
16184000
CY2021Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
19657000
CY2020Q4 us-gaap Deferred Tax Assets Goodwill And Intangible Assets
DeferredTaxAssetsGoodwillAndIntangibleAssets
23006000
CY2021Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
96854000
CY2020Q4 us-gaap Deferred Tax Assets Gross
DeferredTaxAssetsGross
183866000
CY2021Q4 us-gaap Deferred Tax Liabilities Unrealized Gains On Trading Securities
DeferredTaxLiabilitiesUnrealizedGainsOnTradingSecurities
30170000
CY2021Q4 vir Deferred Tax Liabilities Right Of Use Assets
DeferredTaxLiabilitiesRightOfUseAssets
-28483000
CY2019Q4 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Accrued
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestAccrued
0
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4877000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2725000
CY2021Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
69586000
CY2020Q4 us-gaap Deferred Income Tax Liabilities
DeferredIncomeTaxLiabilities
27228000
CY2021Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
45707000
CY2020Q4 us-gaap Deferred Tax Assets Valuation Allowance
DeferredTaxAssetsValuationAllowance
159891000
CY2021Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
18439000
CY2020Q4 us-gaap Deferred Tax Liabilities
DeferredTaxLiabilities
3253000
CY2021 vir Release Of Valuation Allowance Deferred Tax In Amount
ReleaseOfValuationAllowanceDeferredTaxInAmount
114200000
CY2020 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
74100000
CY2019 us-gaap Valuation Allowance Deferred Tax Asset Change In Amount
ValuationAllowanceDeferredTaxAssetChangeInAmount
42300000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7400000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4900000
CY2021Q4 us-gaap Unrecognized Tax Benefits That Would Impact Effective Tax Rate
UnrecognizedTaxBenefitsThatWouldImpactEffectiveTaxRate
0
CY2021 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2020 us-gaap Unrecognized Tax Benefits Income Tax Penalties And Interest Expense
UnrecognizedTaxBenefitsIncomeTaxPenaltiesAndInterestExpense
0
CY2018Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2404000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
0
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromPriorPeriodTaxPositions
133000
CY2021 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
62000
CY2020 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
588000
CY2019 us-gaap Unrecognized Tax Benefits Decreases Resulting From Prior Period Tax Positions
UnrecognizedTaxBenefitsDecreasesResultingFromPriorPeriodTaxPositions
1596000
CY2021 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2607000
CY2020 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
2740000
CY2019 us-gaap Unrecognized Tax Benefits Increases Resulting From Current Period Tax Positions
UnrecognizedTaxBenefitsIncreasesResultingFromCurrentPeriodTaxPositions
1784000
CY2021Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
7422000
CY2020Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
4877000
CY2019Q4 us-gaap Unrecognized Tax Benefits
UnrecognizedTaxBenefits
2725000

Files In Submission

Name View Source Status
0000950170-22-002295-index-headers.html Edgar Link pending
0000950170-22-002295-index.html Edgar Link pending
0000950170-22-002295.txt Edgar Link pending
0000950170-22-002295-xbrl.zip Edgar Link pending
FilingSummary.xml Edgar Link unprocessable
Financial_Report.xlsx Edgar Link pending
img206306002_0.jpg Edgar Link pending
img206306002_1.jpg Edgar Link pending
img206306002_2.jpg Edgar Link pending
img206306002_3.jpg Edgar Link pending
img206306002_4.jpg Edgar Link pending
img206306002_5.jpg Edgar Link pending
img206306002_6.jpg Edgar Link pending
img206306002_7.jpg Edgar Link pending
img206306002_8.jpg Edgar Link pending
img61678762_0.jpg Edgar Link pending
img61678762_1.jpg Edgar Link pending
img61678762_10.jpg Edgar Link pending
img61678762_11.jpg Edgar Link pending
img61678762_12.jpg Edgar Link pending
img61678762_13.jpg Edgar Link pending
img61678762_14.jpg Edgar Link pending
img61678762_15.jpg Edgar Link pending
img61678762_16.jpg Edgar Link pending
img61678762_17.jpg Edgar Link pending
img61678762_18.jpg Edgar Link pending
img61678762_19.jpg Edgar Link pending
img61678762_2.jpg Edgar Link pending
img61678762_20.jpg Edgar Link pending
img61678762_21.jpg Edgar Link pending
img61678762_22.jpg Edgar Link pending
img61678762_23.jpg Edgar Link pending
img61678762_3.jpg Edgar Link pending
img61678762_4.jpg Edgar Link pending
img61678762_5.jpg Edgar Link pending
img61678762_6.jpg Edgar Link pending
img61678762_7.jpg Edgar Link pending
img61678762_8.jpg Edgar Link pending
img61678762_9.jpg Edgar Link pending
MetaLinks.json Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R48.htm Edgar Link pending
R49.htm Edgar Link pending
R5.htm Edgar Link pending
R50.htm Edgar Link pending
R51.htm Edgar Link pending
R52.htm Edgar Link pending
R53.htm Edgar Link pending
R54.htm Edgar Link pending
R55.htm Edgar Link pending
R56.htm Edgar Link pending
R57.htm Edgar Link pending
R58.htm Edgar Link pending
R59.htm Edgar Link pending
R6.htm Edgar Link pending
R60.htm Edgar Link pending
R61.htm Edgar Link pending
R62.htm Edgar Link pending
R63.htm Edgar Link pending
R64.htm Edgar Link pending
R65.htm Edgar Link pending
R66.htm Edgar Link pending
R67.htm Edgar Link pending
R68.htm Edgar Link pending
R69.htm Edgar Link pending
R7.htm Edgar Link pending
R70.htm Edgar Link pending
R71.htm Edgar Link pending
R72.htm Edgar Link pending
R73.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
vir-20211231.htm Edgar Link pending
vir-20211231.xsd Edgar Link pending
vir-20211231_cal.xml Edgar Link unprocessable
vir-20211231_def.xml Edgar Link unprocessable
vir-20211231_htm.xml Edgar Link completed
vir-20211231_lab.xml Edgar Link unprocessable
vir-20211231_pre.xml Edgar Link unprocessable
vir-ex10_43.htm Edgar Link pending
vir-ex10_44.htm Edgar Link pending
vir-ex10_45.htm Edgar Link pending
vir-ex10_46.htm Edgar Link pending
vir-ex10_47.htm Edgar Link pending
vir-ex10_66.htm Edgar Link pending
vir-ex23_1.htm Edgar Link pending
vir-ex31_1.htm Edgar Link pending
vir-ex31_2.htm Edgar Link pending
vir-ex32_1.htm Edgar Link pending